How does hla work

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: The Human Leukocyte Antigen (HLA) system is a group of genes on chromosome 6 that encode proteins essential for immune function, discovered in the 1950s through transplant research. These proteins present antigens to T-cells, triggering immune responses against pathogens or foreign tissues. HLA matching is critical in organ transplantation, with a 6/6 match improving kidney transplant survival rates to over 90% at one year. Over 35,000 HLA alleles have been identified, making it one of the most polymorphic genetic systems in humans.

Key Facts

Overview

The Human Leukocyte Antigen (HLA) system comprises genes encoding cell surface proteins essential for immune recognition, discovered through early transplant research in the 1950s. Located on chromosome 6p21.3, this genetic region spans approximately 3.6 million base pairs and contains over 200 genes, including 21 highly polymorphic classical HLA genes. The system was first identified when Jean Dausset discovered HLA-A2 in 1958 using serological techniques, earning him the 1980 Nobel Prize. HLA proteins are categorized into Class I (HLA-A, -B, -C) expressed on all nucleated cells, and Class II (HLA-DP, -DQ, -DR) primarily on antigen-presenting cells. These molecules display peptide fragments to T-cells, initiating adaptive immune responses. The extreme polymorphism of HLA genes, with over 35,000 identified alleles, creates diverse immune recognition capabilities but complicates tissue matching for transplants.

How It Works

HLA molecules function as antigen-presenting structures that display peptide fragments to T-cells, activating immune responses. Class I HLA molecules present endogenous peptides from intracellular pathogens or abnormal proteins to CD8+ cytotoxic T-cells, triggering destruction of infected cells. Class II molecules present exogenous peptides from extracellular pathogens to CD4+ helper T-cells, initiating antibody production and immune memory. The antigen presentation process begins with protein degradation into peptides by proteasomes (for Class I) or lysosomes (for Class II). These peptides bind to HLA molecules in the endoplasmic reticulum or endosomal compartments, forming stable complexes transported to the cell surface. T-cell receptors recognize specific peptide-HLA combinations, with CD8 or CD4 co-receptors binding to conserved regions of Class I or II molecules respectively. This interaction, along with co-stimulatory signals, determines whether T-cells become activated, tolerant, or anergic.

Why It Matters

The HLA system has profound clinical significance, particularly in transplantation medicine where HLA matching between donor and recipient dramatically affects outcomes. In kidney transplantation, a 6/6 HLA match improves one-year graft survival to over 90%, compared to approximately 70% with poor matches. HLA typing is mandatory for bone marrow transplants, where mismatches can cause fatal graft-versus-host disease. Beyond transplantation, specific HLA alleles strongly associate with autoimmune diseases; HLA-B*27 increases ankylosing spondylitis risk 20-fold, while HLA-DR4 links to rheumatoid arthritis. HLA diversity also influences vaccine responses and susceptibility to infectious diseases like HIV and hepatitis. Pharmacogenomics applications use HLA testing to prevent severe drug reactions, such as HLA-B*57:01 screening before abacavir prescription to avoid hypersensitivity. These applications make HLA understanding crucial for personalized medicine and public health.

Sources

  1. Human leukocyte antigenCC-BY-SA-4.0

Missing an answer?

Suggest a question and we'll generate an answer for it.